Esophageal adenocarcinoma (EA) is increasingly common among patients with Barrett's esophagus (BE). An article in the August issue of Gastroenterology provides consensus recommendations, based on the medical literature, that clinicians can use to manage patients with BE and low-grade dysplasia, high-grade dysplasia (HGD), or early-stage EA. Dr. Kuemmerle speaks to lead author Dr. Janusz Jankowski of the Blizard Institute, Queen Mary, University of London; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.